*Yuji Yamada¹, Tomiki Sumiyoshi² (1. National Center of Neurology and Psychiatry, 2. National Center of Neurology and Psychiatry)

*Keiko Ikemoto¹ (1. Iwaki City Medical Center)

*Yuriko Iwakura^1,2, Ryoka Kawahara-Miki³, Satoshi Kida^4,5, Hidekazu Sotoyama², Ramil Gabdulkhaev⁶, Hitoshi Takahashi⁶, Yasuto Kunii^7,8, Mizuki Hino^7,8, Atsuko Nagaoka⁷, Ryuta Izumi⁷, Risa Shishido⁷, Toshiyuki Someya⁹, Hirooki Yabe⁷, Akiyoshi Kakita⁶, Hiroyuki Nawa^10,2 (1. 新潟大学脳研究所腫瘍病態学分野、2. 新潟大学脳研究所分子神経生物学分野、3. 東京農業大学生物資源ゲノム解析センター、4. 東京大学大学院農学生命科学研究科、5. 東京農業大学生命科学部バイオサイエンス学科、6. 新潟大学脳研究所病理学分野、7. 福島県立医科大学医学部神経精神医学講座、8. 東北大学災害科学国際研究所災害精神医学分野、9. 新潟大学大学院医歯学総合研究科精神医学分野、10. 和歌山県立医科大学生体機能解析学研究室)

*Charalampos Brakatselos¹, George Ntoulas¹, Michail Zois Asprogerakas¹, Olga Tsarna¹, Alexia Polissidis², Joana Silva³, Ioannis Sotiropoulos³, Joao Filipe Oliveira³, Katerina Antoniou¹ (1. Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece, 2. Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, 4 Soranou Efesiou Str, 11527 Athens, Greece, 3. Life and Health Sciences Research Institute (ICVS), University of Minho, Braga, Portugal ICVS/3B’s, PT Government Associate Laboratory, Braga, Portugal)

*Felisa Maria Herrero¹, Joel Gruchot², Hervé Perron^3,4, Patrick Küry², Ulrike Weber-Stadlbauer^1,5, Urs Meyer^1,5 (1. Institute of Pharmacology and Toxicology, University of Zurich-Vetsuisse, Zurich, Switzerland, 2. Department of Neurology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany, 3. GeNeuro, 3, Chemin du pré Fleuri 1228 Plan-les-Ouates, Geneva, Switzerland, 4. Université de Lyon-UCBL, Lyon, France, 5. Neuroscience Center Zurich, Zurich, Switzerland)